Adverse Reactions and Pathogen Safety of Intravenous Immunoglobulin

E-ISSN： 2212-3911|2|1|9-18

ISSN： 1574-8863

Source： Current Drug Safety, Vol.2, Iss.1, 2007-01, pp. : 9-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Administering intravenous immunoglobulin during infection is associated with infusion reactions in selected patients

By Khan S.

Irish Journal of Medical Science, Vol. 180, Iss. 1, 2011-03 ,pp. : 125-128

Springer Publishing Company

Access to resources Recommend Favorite

Adverse Drug Reactions and Safety Considerations of NSAIDs: Clinical Analysis

Current Drug Safety, Vol. 6, Iss. 5, 2011-11 ,pp. : 310-317

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and Safety of the New Intravenous Immunoglobulin IGIV 10% in Adults with Chronic Idiopathic Thrombocytopenic Purpura

Transfusion Medicine and Hemotherapy, Vol. 33, Iss. 6, 2006-10 ,pp. : 509-514

Karger

Access to resources Recommend Favorite

Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients

By Wozniacka Anna Sysa-jedrzejowska Anna Robak Ewa Samochocki Zbigniew Zak-prelich Malgorzata

Mediators of Inflammation, Vol. 12, Iss. 2, 2003-01 ,pp. : 95-99

Informa Healthcare

Access to resources Recommend Favorite

Influence of Intravenous Immunoglobulin Treatment on Thrombopoiesis

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 3, 2012-05 ,pp. : 217-220

Karger

Access to resources Recommend Favorite